Genopole thus joins the network’s other 130 EU|BICs, chosen for their ability to stimulate the economic development of European regions. Lauded for its expertise in biotechnological innovation, Genopole is currently the only EU|BIC-certified cluster in the Île-de-France Administrative Region.
The EU|BIC trademark confirms the value of Genopole’s domiciliary, technological, scientific and entrepreneurial service offer for enabling the creation and development of innovative companies.
Genopole’s Shaker, a unique program in France, puts those who have innovative projects on the path toward business creation (Shaker call for candidates).
Its Booster program provides start-ups with strategic accompaniment to accelerate fund-raising and consolidate business.
More mature companies gain in international visibility at Genopole and benefit from on-site partnering and recruiting opportunities.
Gilles Lasserre, Chief Executive of Genopole: “This EU|BIC certification is a testimonial to our actions, carried out with Île-de-France’s plethora of talents and resources, to support innovation and the economic development of the region. The EU|BIC trademark strengthens our national & European visibility, and it will undeniably contribute to the growth we are aiming for, within and without. The certification will also serve Genopole as a vector for novel European interactions beyond the field of health, for example in agritech or foodtech, sectors that are rich in disruptive innovations.“